Document Detail

Outcomes After Urothelial Recurrence in Bladder Cancer Patients Undergoing Radical Cystectomy.
MedLine Citation:
PMID:  25306479     Owner:  NLM     Status:  Publisher    
OBJECTIVE: To identify factors prognostic for survival after urothelial recurrence after radical cystectomy for bladder cancer.
METHODS: Of the 2029 patients with bladder cancer who underwent radical cystectomy at our institution, 80 (3.9%) patients experienced recurrence in the urothelium (upper urinary tract or urethra) and had sufficient follow-up for further analysis. Clinicopathologic characteristics were analyzed by univariate and multivariable analyses to identify factors prognostic for postrecurrence disease-specific (PRDSS) and overall (PROS) survival.
RESULTS: At median follow-up of 12 years, 25 (31.3%) and 55 (68.7%) patients experienced recurrence in the upper tract and urethra, respectively. Median time to recurrence, PRDSS, and PROS were 25.9, 58.4, and 48.7 months, respectively. Older age (P = .018), patients with tumors that were upstaged at cystectomy compared with their clinical stage (P = .049), and positive surgical margins (P = .022) were associated with a lower PROS. The presence of symptoms at follow-up was associated with a poor PRDSS (P = .028), which was confirmed by multivariable analysis. Patients experiencing urothelial recurrence within 2 years of cystectomy had a lower PRDSS (P = .002) and PROS (P = .003), which was confirmed by multivariable analysis. Site of urothelial recurrence did not influence time to recurrence (P = .87), PRDSS (P = .72), or PROS (P = .57).
CONCLUSION: Urothelial cancer relapse in the upper urinary tract or urethra has a comparable clinical course, and may be cured with extirpative surgery, with median PROS of 48.7 months after recurrence. Patients experiencing early urothelial recurrence face worse prognosis and should be considered candidates for adjuvant therapy.
Anirban P Mitra; Mehrdad Alemozaffar; Brianna N Harris; Anne K Schuckman; Eila C Skinner; Siamak Daneshmand
Related Documents :
25419379 - Prognostic significance of high-risk human papillomavirus and p16(ink4a) in patients wi...
25442339 - Standard (60 gy) or short-course (40 gy) irradiation plus concomitant and adjuvant temo...
16052429 - The role of radiation therapy in non-small cell lung cancer.
25436289 - Intranodal cytokeratin particles is a predictive marker of efficacy for neoadjuvant the...
25421199 - Reduced dose of bacillus calmette-guérin versus full dose of bacillus calmette-guérin f...
25375129 - Prognoses and long-term outcomes of nasopharyngeal carcinoma in han and uyghur patients...
8486529 - Use of serum gamma-enolase and aldolase a in combination as markers for renal cell carc...
15117039 - Results of radiotherapy in non round cell spinal metastasis.
18255129 - Pcr detection rates of high risk human papillomavirus dna in paired self-collected urin...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-10-9
Journal Detail:
Title:  Urology     Volume:  -     ISSN:  1527-9995     ISO Abbreviation:  Urology     Publication Date:  2014 Oct 
Date Detail:
Created Date:  2014-10-12     Completed Date:  -     Revised Date:  2014-10-13    
Medline Journal Info:
Nlm Unique ID:  0366151     Medline TA:  Urology     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2014 Elsevier Inc. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Role of Nocturnal Penile Erection Test on Response to Daily Sildenafil in Patients With Erectile Dys...
Next Document:  Reconstruction of Penile Urethra With the 3-Dimensional Porous Bladder Acellular Matrix in a Rabbit ...